АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология

Атипичные антипсихотики. Alvir JMJ, Lieberman JA, Safferman AZ, et al

Alvir JMJ, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 1993; 329:162.

Brier AF, Malhotra AK, Su T-P, et al. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Am J Psychiatry 1999; 156:294.

Kane J, Honigfeld G, Singer J, et al. The Clozaril Collaborative Study Group: clozapine for the treatment-resistant schizophrenic. A double-blind comparison vs. chlorpromazine/benztropine. Arch Gen Psychiatry 1988; 45:769.

Sanger TM, Lieberman JA, Tohen M, et al. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry 1999; 156:79.

Small JG, Hirsch SR, Arvantis LA, et al. Quetiapine in patients with schizophrenia. Arch Gen Psychiatry 1997; 54:549.

Wahlbeck K, Cheine M, Essali A, et al. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999; 156:990.

Wirshing DA, Marshall BD, Green MF, et al. Risperidone in treatment-refractory schizophrenia. Am J Psychiatry 1999; 156:1374.

Антипсихотики-депо

Carpenter WT Jr, Buchanan RW, Kirkpatrick B, et al. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks. Am J Psychiatry 1999; 156:412.

Дата добавления: 2015-07-23 | Просмотры: 724 | Нарушение авторских прав